Table of Contents

Table of Contents

Case Report

Specular Microscopic Imaging Results May Be Deceiving, as Demonstrated by Vital Dye Staining

Global Perspectives

The Eye Bank Association of Australia and New Zealand: Origins, History, Activity and Future.

Original Research

Potential Adverse Effects on the Cornea Donor Pool in 2031

Donor Endothelial Specular Image Quality in Optisol GS and Life4˚C

Picture Challenge

Picture Challenge: What is This?

Potential Adverse Effects on the Cornea Donor Pool in 2031


Woodford Spears Van Meter, MD, Preeti Haresh Sheth


eye bank, corneal transplantation, hepatitis B, hepatitis C


PURPOSE: To evaluate to adequacy of the cornea donor pool in 2031.

METHODS: Cornea supply and utilization data are obtained from the EBAA statistical report and compared with population data projections from the US Census Bureau. The rate of utilization can be extrapolated by linear best-fit analysis of the previous 5 years tissue utilization trends to estimate tissue needs in 2031. Similarly, the effects of hepatitis B, hepatitis C, and medical-social history on the donor pool can be projected.

RESULTS: The US population is expected to increase 16% over the next 20 years, but the rate of tissue utilization based on the last five years suggests the need for cornea tissue will increase nearly 133% in the next 20 years. If the trends from 2006 to 2011 continue over the next 20 years, the rate of donors testing positive for hepatitis B is projected to increase 275% and for hepatitis C, 241%, permanently eliminating them from the donor pool. In the same fashion, the number of patients eliminated from the donor pool because of medical-social history findings is estimated to increase 237% over the next 20 years.

CONCLUSIONS: The need for donor corneas over the next 20 years will increase proportionally much faster than the US population is growing. Potential donors eliminated because of hepatitis B and C and medical-social history are projected to increase as well. Public education programs, such as Donate Life America, which increase the number of consenting donors and mechanisms to enhance corneal preservation prior to surgery, should be started now.




Zirm E. Eine erfolgreche totale keratiplastik. Arch Ophthalmol. 1906;64:580-593.

Filatov VP. Transplantation of the Cornea. Arch Ophthalmol. 1935;13:321-47.

Castroviejo R. Present status of keratoplasty. Arch Ophthalmol. 1939; 22:114-126.

Eye Bank for Sight Restoration, 120 Wall Street, New York, NY.

Paton, D. Chapter 17. R. Townley Paton, In: Mannis MJ, Mannis AA, Albert DM. Corneal Transplantation: A History in Profiles. Hirschberg History of Ophthalmology, Monographs. Oostende, Belgium: Wayenborgh Press. 1999(6):239-263.

Cordes, FC. Federation of Eye Banks [editorial]. Am J Ophthalmol. 1956;41:140-142.

Cordes, FC. The Eye Bank Committee [editorial]. Am J Ophthalmol. 1957;43:310-311.

King, JH. Eye Bank Programs. Am J Ophthalmol. 1962;54:5.

Eye Bank Association of America, 1015 18th Street NW, Washington, DC.

Chu, W. The past twenty-five years in eye banking. Cornea. 2000;19(5):754-765. PMID 11009327.

The 2011 Eye Banking Statistical Report. Eye Bank Association of America, 1015 18th Street NW, Washington, DC. (202) 775-4999.

Hazard (KY) Herald, 2007.

Rowan County Chamber of Commerce, Morehead, KY, 2009.

Kentucky Donor Registry. Winchester (Clark County) Kentucky, 2012.

Sugar A, Montoya M, Beck R, et al. The impact of the Corneal Donor Study on acceptance of corneas from older donors. Cornea. 2012;31(12):1441-5. Doi:1097/ICO.0b013e31823f7550.

Duffy P, Wolf J, Collins G, et al. Letter: possible person-to-person transmission of Creutzfield-Jakob disease. N Engl J Med. 1974;290(12):692-3. PMID: 4591849.

Kennedy RH, et al. Summary report by committee on prion disease, commissioned by EBAA. January 27, 2000. Washington, DC: EBAA.


Article PDF

Fullscreen Mode